Literature DB >> 1426882

Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients.

T Tomiya1, M Tani, S Yamada, S Hayashi, N Umeda, K Fujiwara.   

Abstract

Serum hepatocyte growth factor levels were measured in hepatectomized and nonhepatectomized surgical patients. The levels were significantly increased and reached a maximum within 7 days after surgery in both groups, returning to preoperative levels 28 days after partial hepatectomy and 7 days after other operations. Multiple regression analysis showed that such maximal hepatocyte growth factor levels were significantly related to having liver cirrhosis and postoperative maximal serum total bilirubin and alanine aminotransferase levels and peripheral white blood cell counts in the hepatectomized group and to postoperative maximal peripheral white blood cell counts and serum C-reactive protein levels in the nonhepatectomized group. However, the levels showed no relation to the resected liver volume and increment of the remaining liver volume 28 days after partial hepatectomy. It is concluded that serum hepatocyte growth factor levels were increased after partial hepatectomy in association with hepatocellular dysfunction and necrosis and systemic inflammation. It is unlikely that the increase was related to liver regeneration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426882     DOI: 10.1016/0016-5085(92)91186-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Changes in splenic volume during liver regeneration.

Authors:  Hideya Ando; Masato Nagino; Toshiyuki Arai; Hideki Nishio; Yuji Nimura
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

2.  Plasma hepatocyte growth factor levels are increased in systemic inflammatory response syndrome.

Authors:  M Sakon; Y Kita; T Yoshida; K Umeshita; M Gotoh; T Kanai; T Kawasaki; J Kambayashi; M Monden
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Oval cell response in 2-acetylaminofluorene/partial hepatectomy rat is attenuated by short interfering RNA targeted to stromal cell-derived factor-1.

Authors:  Donghang Zheng; Seh-hoon Oh; Youngmi Jung; Bryon E Petersen
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration.

Authors:  T Tomiya; I Ogata; K Fujiwara
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Significant changes in the serum levels of IL-6, h-HGF, and type IV collagen 7S during the perioperative period of a hepatectomy: relevance to SIRS.

Authors:  K Namekata; S Takamori; K Kojima; T Beppu; S Futagawa
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  Liver regeneration is an angiogenesis- associated phenomenon.

Authors:  Tom A Drixler; Mathys J Vogten; Ewan D Ritchie; Theo J M V van Vroonhoven; Martijn F B G Gebbink; Emile E Voest; Inne H M Borel Rinkes
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

Review 7.  MET: roles in epithelial-mesenchymal transition and cancer stemness.

Authors:  Hye-Min Jeon; Jeongwu Lee
Journal:  Ann Transl Med       Date:  2017-01

8.  Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.

Authors:  Kyung Hee Lee; Eun Young Choi; Myung Soo Hyun; Byung Ik Jang; Tae Nyeun Kim; Heon Ju Lee; Jong Yuel Eun; Hong Gin Kim; Sung Soo Yoon; Dong Sik Lee; Jung Hye Kim; Jae-Ryong Kim
Journal:  Clin Exp Metastasis       Date:  2007-11-09       Impact factor: 5.150

9.  Mechanisms of splenic hypertrophy following hepatic resection.

Authors:  Gheorghe Petrovai; Stéphanie Truant; Carole Langlois; Ahmed F Bouras; Stéphanie Lemaire; David Buob; Emmanuelle Leteurtre; Emmanuel Boleslawski; François-René Pruvot
Journal:  HPB (Oxford)       Date:  2013-02-26       Impact factor: 3.647

Review 10.  Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

Authors:  V Finisguerra; H Prenen; M Mazzone
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.